Dana-Farber Cancer Institute • Center for Thoracic Oncology

Study Coordinator Dashboard

Review active trial recruitment campaigns, screen de-identified patient cases registered on sites.eligara.ai, and send in-app interest notifications.

New Trial Candidate Search
Active Trials Enrolling
2 Trials
Thoracic & Breast Oncology
Cases Analyzed by LLM
5 Cases
From sites.eligara.ai cases
Candidates in Basket
2 Shortlisted
Review & Send Outreach →
Patient Interested
1 Response
Contact unlocked for Candidate #PT-4109

Active Trial Recruitment Campaigns

2 active protocols
Active Recruiting NCT05481234 • Phase 2

Phase 2 Study of Targeted Combination Therapy in EGFR-Mutated Advanced NSCLC

Sponsor: Dana-Farber Cancer Institute / Alliance Oncology • Target Condition: Non-Small Cell Lung Cancer (NSCLC)
Recruitment Specs: Recruiting adult patients with sensitizing EGFR mutations who have experienced radiological disease progression on standard frontline therapy. Asymptomatic treated CNS metastases allowed.
Biomarkers: EGFR Exon 19 del, EGFR L858R, T790M-negative Stage: Stage IIIB, IV, or Recurrent ECOG: 0 - 1 Radius: 50 miles from Boston, MA
Active Recruiting NCT05928811 • Phase 1b/2

Novel ADC Conjugate Trial for Pretreated HER2-Low Metastatic Breast Cancer

Sponsor: Massachusetts General Hospital Cancer Center • Target Condition: Metastatic Breast Cancer (HER2-Low)
Recruitment Specs: Patients must have centrally confirmed HER2-low status by recent biopsy, documented progression on prior endocrine or cytotoxic regimen.
Biomarkers: HER2 IHC 1+ or 2+/ISH-, HR+ or HR- Stage: Metastatic (Stage IV) ECOG: 0 - 1 Radius: 75 miles from Boston, MA

How Eligara Recruit Connects Coordinators with Patients

STEP 1

Define Trial Specs

Enter trial name, clinical criteria, biomarker requirements, and geographic catchment.

STEP 2

LLM Case Screening

Eligara's matching engine screens patient cases from sites.eligara.ai while keeping patient names and symbolic titles completely hidden.

STEP 3

Basket & In-App Outreach

Add qualified cases to your basket and send an in-app notification of interest. The patient sees the invite inside sites.eligara.ai and chooses whether to connect.